139 related articles for article (PubMed ID: 37407446)
21. Assessment of Y chromosome copy number alterations in non-neoplastic and neoplastic leukocytes of male dogs.
Mochizuki H; Estrada AJ; Boggess M
Vet J; 2024 Apr; 304():106088. PubMed ID: 38412887
[TBL] [Abstract][Full Text] [Related]
22. Aberrations of the FHIT gene and Fhit protein in canine lymphoma cell lines.
Hiraoka H; Minami K; Kaneko N; Shimokawa Miyama T; Okamura Y; Mizuno T; Okuda M
J Vet Med Sci; 2009 Jun; 71(6):769-77. PubMed ID: 19578286
[TBL] [Abstract][Full Text] [Related]
23. Survivin inhibition via EZN-3042 in canine lymphoma and osteosarcoma.
Shoeneman JK; Ehrhart EJ; Charles JB; Thamm DH
Vet Comp Oncol; 2016 Jun; 14(2):e45-57. PubMed ID: 24923332
[TBL] [Abstract][Full Text] [Related]
24. Optically active stereoisomers of 5-(1-iodoethyl)-4-(4'-isopropylphenyl)dihydrofuran-2-one: The effect of the configuration of stereocenters on apoptosis induction in canine cancer cell lines.
Pawlak A; Gładkowski W; Mazur M; Henklewska M; Obmińska-Mrukowicz B; Rapak A
Chem Biol Interact; 2017 Jan; 261():18-26. PubMed ID: 27867085
[TBL] [Abstract][Full Text] [Related]
25. Identification of altered MicroRNA expression in canine lymphoid cell lines and cases of B- and T-Cell lymphomas.
Uhl E; Krimer P; Schliekelman P; Tompkins SM; Suter S
Genes Chromosomes Cancer; 2011 Nov; 50(11):950-67. PubMed ID: 21910161
[TBL] [Abstract][Full Text] [Related]
26. Dynamic changes in DNA methylation patterns in canine lymphoma cell lines demonstrated by genome-wide quantitative DNA methylation analysis.
Yamazaki J; Jelinek J; Hisamoto S; Tsukamoto A; Inaba M
Vet J; 2018 Jan; 231():48-54. PubMed ID: 29429487
[TBL] [Abstract][Full Text] [Related]
27. Authentication of primordial characteristics of the CLBL-1 cell line prove the integrity of a canine B-cell lymphoma in a murine in vivo model.
Rütgen BC; Willenbrock S; Reimann-Berg N; Walter I; Fuchs-Baumgartinger A; Wagner S; Kovacic B; Essler SE; Schwendenwein I; Nolte I; Saalmüller A; Murua Escobar H
PLoS One; 2012; 7(6):e40078. PubMed ID: 22761949
[TBL] [Abstract][Full Text] [Related]
28. Correlations between numerical chromosomal aberrations in the tumor and peripheral blood in canine lymphoma.
Devitt JJ; Maranon DG; Ehrhart EJ; Bachand AM; Lana SE; LaRue SM
Cytogenet Genome Res; 2009; 124(1):12-8. PubMed ID: 19372664
[TBL] [Abstract][Full Text] [Related]
29. Comprehensive genomic characterization of five canine lymphoid tumor cell lines.
Roode SC; Rotroff D; Richards KL; Moore P; Motsinger-Reif A; Okamura Y; Mizuno T; Tsujimoto H; Suter SE; Breen M
BMC Vet Res; 2016 Sep; 12():207. PubMed ID: 27639374
[TBL] [Abstract][Full Text] [Related]
30. Simultaneous Analysis of the p16 Gene and Protein in Canine Lymphoma Cells and Their Correlation with pRb Phosphorylation.
Maylina L; Kambayashi S; Baba K; Okuda M
Vet Sci; 2022 Jul; 9(8):. PubMed ID: 36006308
[TBL] [Abstract][Full Text] [Related]
31. Validating the anti-lymphoma pharmacodynamic actions of the endocannabinoids on canine non-Hodgkin lymphoma.
Omer S; Pathak S; Nadar R; Bowen D; Sandey M; Dhanasekaran M; Pondugula S; Mansour M; Boothe D
Life Sci; 2023 Aug; 327():121862. PubMed ID: 37330042
[TBL] [Abstract][Full Text] [Related]
32. Building a better dynasore: the dyngo compounds potently inhibit dynamin and endocytosis.
McCluskey A; Daniel JA; Hadzic G; Chau N; Clayton EL; Mariana A; Whiting A; Gorgani NN; Lloyd J; Quan A; Moshkanbaryans L; Krishnan S; Perera S; Chircop M; von Kleist L; McGeachie AB; Howes MT; Parton RG; Campbell M; Sakoff JA; Wang X; Sun JY; Robertson MJ; Deane FM; Nguyen TH; Meunier FA; Cousin MA; Robinson PJ
Traffic; 2013 Dec; 14(12):1272-89. PubMed ID: 24025110
[TBL] [Abstract][Full Text] [Related]
33. In vitro antineoplastic effects of auranofin in canine lymphoma cells.
Zhang H; Rose BJ; Pyuen AA; Thamm DH
BMC Cancer; 2018 May; 18(1):522. PubMed ID: 29724201
[TBL] [Abstract][Full Text] [Related]
34. Analyses on activation of NF-κB and effect of bortezomib in canine neoplastic lymphoid cell lines.
Kojima K; Fujino Y; Goto-Koshino Y; Ohno K; Tsujimoto H
J Vet Med Sci; 2013; 75(6):727-31. PubMed ID: 23337362
[TBL] [Abstract][Full Text] [Related]
35. Studying the DNA damage response pathway in hematopoietic canine cancer cell lines, a necessary step for finding targets to generate new therapies to treat cancer in dogs.
Hernández-Suárez B; Gillespie DA; Dejnaka E; Kupczyk P; Obmińska-Mrukowicz B; Pawlak A
Front Vet Sci; 2023; 10():1227683. PubMed ID: 37655260
[TBL] [Abstract][Full Text] [Related]
36. Ubiquitin-specific protease 7 as a potential therapeutic target in dogs with hematopoietic malignancies.
Pawlak A; Bajzert J; Bugiel K; Hernández Suárez B; Kutkowska J; Rapak A; Hildebrand W; Obmińska-Mrukowicz B; Freire R; Smits VAJ
J Vet Intern Med; 2021 Mar; 35(2):1041-1051. PubMed ID: 33650720
[TBL] [Abstract][Full Text] [Related]
37. JAK1/2 Inhibitors AZD1480 and CYT387 Inhibit Canine B-Cell Lymphoma Growth by Increasing Apoptosis and Disrupting Cell Proliferation.
Lu Z; Hong CC; Jark PC; Assumpção ALFV; Bollig N; Kong G; Pan X
J Vet Intern Med; 2017 Nov; 31(6):1804-1815. PubMed ID: 28960447
[TBL] [Abstract][Full Text] [Related]
38. SRC-induced disintegration of adherens junctions of madin-darby canine kidney cells is dependent on endocytosis of cadherin and antagonized by Tiam-1.
Palovuori R; Sormunen R; Eskelinen S
Lab Invest; 2003 Dec; 83(12):1901-15. PubMed ID: 14691308
[TBL] [Abstract][Full Text] [Related]
39. 3D-culture models as drug-testing platforms in canine lymphoma and their cross talk with lymph node-derived stromal cells.
An JH; Song WJ; Li Q; Bhang DH; Youn HY
J Vet Sci; 2021 May; 22(3):e25. PubMed ID: 33908202
[TBL] [Abstract][Full Text] [Related]
40. Genome-wide DNA methylation analysis in canine gastrointestinal lymphoma.
Ohta H; Yamazaki J; Jelinek J; Ishizaki T; Kagawa Y; Yokoyama N; Nagata N; Sasaki N; Takiguchi M
J Vet Med Sci; 2020 May; 82(5):632-638. PubMed ID: 32213750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
